Every Second Counts: Urgent Call to Protect Children at Risk of Anaphylaxis in Schools
Berlin — For children with severe allergies, a single bite of the wrong food or an unexpected encounter with latex can trigger anaphylaxis—a life-threatening allergic reaction that demands immediate action. Yet across Europe, schools remain alarmingly unprepared to respond, leaving millions of young lives at risk. This week, the European Academy of Allergy and Clinical Immunology (EAACI) issued a stark warning: every minute counts, and without urgent, standardized safety measures, preventable tragedies will continue to occur in classrooms.
Anaphylaxis is a rapid, systemic allergic reaction that can escalate from mild symptoms—such as hives or itching—to full respiratory collapse within minutes. For children, the stakes are particularly high: studies show that nearly 8% of European children live with food allergies, and up to 2% are at risk of anaphylaxis. Despite these numbers, many schools lack basic protocols, trained staff, or access to life-saving epinephrine auto-injectors—devices that can halt anaphylaxis in its tracks if administered quickly.
EAACI’s call to action, supported by leading allergy organizations in Spain—including the Spanish Association of People with Food and Latex Allergy (AEPNAA), the Spanish Society of Allergology and Clinical Immunology (SEAIC), and the Spanish Society of Pediatric Allergy, Asthma, and Clinical Immunology (SEICAP)—highlights a critical gap in public health policy. While some countries have introduced guidelines for anaphylaxis management in schools, enforcement is inconsistent, and many regions still operate without any mandatory safety measures at all. The result? A patchwork of protection that leaves children vulnerable depending on where they live.
The Human Cost of Delay
In 2023, a study published in *Pediatric Allergy and Immunology* found that anaphylaxis incidents in European schools had risen by 30% over the past decade, with food allergies accounting for the majority of cases. Peanuts, tree nuts, milk, eggs, and sesame are among the most common triggers, but latex—found in school supplies like gloves, balloons, and even some art materials—as well poses a significant risk. For children with latex allergies, even routine activities like blowing up balloons or handling science lab equipment can turn deadly.
The consequences of delayed or improper response are devastating. In 2022, a 12-year-old boy in Spain died after suffering an anaphylactic reaction to peanuts during a school trip. Investigations later revealed that while the school had an epinephrine auto-injector on site, staff were untrained in its leverage, and the device was not administered until emergency services arrived—nearly 20 minutes after symptoms first appeared. Similar cases have been reported in the UK, France, and Germany, where schools either lacked emergency medication or failed to recognize the signs of anaphylaxis in time.
“Anaphylaxis is not just a medical emergency. it’s a time-sensitive crisis,” said Dr. María José Torres, President of SEAIC, in a statement released by EAACI. “When a child’s airway begins to close, every second without treatment increases the risk of permanent injury or death. Schools must be equipped to act immediately—not after a 911 call, not after a teacher consults a manual, but within the first critical minutes.”
A Patchwork of Policies: Why Europe’s Schools Are Failing
Europe’s approach to anaphylaxis safety in schools is fragmented at best. While some countries, like the UK and France, have introduced national guidelines requiring schools to stock epinephrine auto-injectors and train staff in their use, others have no such mandates. In Spain, for example, regional governments set their own policies, leading to stark disparities: a child in Catalonia may have access to emergency medication and trained personnel, while a child in Andalusia may not. Even within countries with guidelines, compliance is often voluntary, leaving schools to decide whether to prioritize safety.
This lack of standardization is particularly concerning given the mobility of families across Europe. A child with a severe peanut allergy who moves from a school in Sweden—where anaphylaxis training is mandatory—to one in Italy, where no such requirement exists, faces a sudden and dangerous drop in protection. “Families should not have to research school safety policies like they’re choosing a neighborhood based on crime rates,” said AEPNAA spokesperson Ana Gómez. “Anaphylaxis is a universal risk, and the response to it should be universal, too.”
Compounding the issue is a widespread lack of awareness among educators. A 2024 EAACI survey of 1,200 European teachers found that only 42% could correctly identify the signs of anaphylaxis, and just 35% knew how to use an epinephrine auto-injector. Many teachers admitted to feeling “overwhelmed” by the responsibility, with some expressing fear of legal repercussions if they administered medication incorrectly. This hesitation can prove fatal: in cases where epinephrine is delayed, the risk of death increases by up to 50%.
What Needs to Change: A Roadmap for Safety
EAACI and its partner organizations are urging policymakers to adopt a three-pronged approach to close the safety gap in schools:
- Mandatory epinephrine stocking: Every school, regardless of location, should be required to keep at least two unassigned epinephrine auto-injectors on site—one for general use and one as a backup. These devices should be stored in easily accessible locations, such as the school office or nurse’s station, and clearly labeled.
- Standardized training: All school staff, from teachers to cafeteria workers to bus drivers, should receive annual training on recognizing anaphylaxis and administering epinephrine. Training should be practical, not just theoretical, and include hands-on demonstrations with trainer devices.
- National registries and action plans: Schools should maintain up-to-date records of students with known allergies, including individualized emergency action plans developed in collaboration with parents and healthcare providers. These plans should outline specific triggers, symptoms, and step-by-step response protocols.
Some countries are already making progress. In 2023, Portugal became the first European nation to pass a law requiring all schools to stock epinephrine and train staff in its use. Similar legislation is under consideration in Belgium and the Netherlands, while the UK’s Department for Education has updated its guidelines to emphasize the importance of “immediate action” in anaphylaxis cases.
However, experts warn that legislation alone is not enough. “Policies are only as good as their implementation,” said Dr. Torres. “We need to see real investment in training, in public awareness campaigns, and in holding schools accountable for compliance. This isn’t about bureaucracy; it’s about saving lives.”
The Role of Parents and Communities
While systemic change is essential, parents and caregivers also play a critical role in advocating for safer schools. EAACI recommends the following steps for families of children with allergies:
- Develop an emergency action plan: Work with your child’s allergist to create a written plan outlining their specific triggers, symptoms, and response steps. Share this plan with the school and ensure all staff are familiar with it.
- Provide your own epinephrine: Even if a school stocks unassigned auto-injectors, parents should provide at least two prescribed devices for their child—one to carry with them and one to keep at the school. These should be labeled with the child’s name and stored in a secure but accessible location.
- Educate your child: Teach your child to recognize their own symptoms, avoid their triggers, and advocate for themselves. Role-playing scenarios can assist build confidence in high-pressure situations.
- Advocate for change: Join or support local and national allergy advocacy groups, such as AEPNAA in Spain or Anaphylaxis UK. These organizations work to raise awareness, push for policy changes, and provide resources for families and schools.
For schools, the message is clear: anaphylaxis is not a rare or distant threat. We see a daily reality for millions of European children, and the tools to prevent tragedy are already available. What’s missing is the collective will to act.
Looking Ahead: The Next Steps for Policymakers
EAACI’s call to action comes at a pivotal moment. In May 2026, the European Parliament will debate a resolution on school safety standards, which includes provisions for anaphylaxis preparedness. Advocacy groups are urging lawmakers to seize this opportunity to establish EU-wide guidelines, ensuring that no child’s safety depends on their postal code.
In the meantime, parents, teachers, and healthcare providers are being asked to sign EAACI’s petition demanding urgent action. The goal is to present 100,000 signatures to the European Commission by the end of 2026, demonstrating widespread public support for standardized anaphylaxis protocols in schools.
“This is not a complex problem to solve,” said Gómez. “We have the knowledge, the tools, and the examples of countries that are getting it right. What we need now is the political courage to make it happen everywhere. For the sake of our children, we cannot afford to wait another day.”
Key Takeaways
- Anaphylaxis is a life-threatening allergic reaction that can escalate to respiratory failure within minutes, requiring immediate treatment with epinephrine.
- Up to 8% of European children have food allergies, and 2% are at risk of anaphylaxis, yet many schools lack basic safety protocols.
- Europe’s approach to school anaphylaxis safety is fragmented, with policies varying widely between and within countries, leaving children vulnerable depending on where they live.
- EAACI and partner organizations are calling for mandatory epinephrine stocking, standardized staff training, and national registries of students with allergies.
- Parents can advocate for change by developing emergency action plans, providing their own epinephrine, and supporting advocacy groups.
- The European Parliament will debate school safety standards in May 2026, presenting an opportunity to establish EU-wide guidelines for anaphylaxis preparedness.
As the debate over school safety continues, one fact remains indisputable: when it comes to anaphylaxis, every second counts. The question is whether Europe’s leaders will act in time to ensure that no child’s life is lost to a preventable tragedy.
Have you or someone you understand been affected by anaphylaxis in a school setting? Share your story in the comments below, and help raise awareness by sharing this article with your network. Together, we can turn the tide on this urgent public health issue.